Canada « Science and Enterprise

Trial Shows Broad Coronavirus Immune Response

By Alan, on September 27th, 2023%

Initial results from a clinical trial show an experimental vaccine produces immune responses in healthy adults against Covid-19 variants and a range of other coronaviruses. . . . → Read More: Trial Shows Broad Coronavirus Immune Response

NIH Challenge Seeks Early Alzheimer’s Indicators with A.I.

By Alan, on September 7th, 2023%

A new crowdsourced competition seeks more robust early indicators of Alzheimer’s disease and related dementias using analytics powered by artificial intelligence. . . . → Read More: NIH Challenge Seeks Early Alzheimer’s Indicators with A.I.

Streamlined Gene Therapy Delivery Process Demonstrated

By Alan, on July 27th, 2023%

A group of academic and industry researchers exhibited in lab cells and mice a more direct delivery technique that could make gene therapies more accessible and inexpensive. . . . → Read More: Streamlined Gene Therapy Delivery Process Demonstrated

Bio-Friendly Plant Nutrient Delivery Patent Awarded

By Alan, on July 10th, 2023%

A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent. . . . → Read More: Bio-Friendly Plant Nutrient Delivery Patent Awarded

Safer Forms of Psilocybin Assessed in Preclinical Study

By Alan, on May 22nd, 2023%

A biotechnology company says it identified engineered precursors of a psychedelic compound that in lab animals produce safe and intended therapeutic effects. . . . → Read More: Safer Forms of Psilocybin Assessed in Preclinical Study

$15M Alternative Chicken, Fish Challenge Finalists Named

By Alan, on May 10th, 2023%

An international challenge competition seeking sustainable but realistic alternatives to natural chicken and fish protein named its six finalist teams. . . . → Read More: $15M Alternative Chicken, Fish Challenge Finalists Named

Computational Drug Discovery Company Acquires A.I. Businesses

By Alan, on May 8th, 2023%

Two companies using artificial intelligence to advance biotechnology and design new therapies are merging with a computational-engineering drug discovery enterprise. . . . → Read More: Computational Drug Discovery Company Acquires A.I. Businesses

Trial Shows Plant-Based Drug Helps Reduce Vaping

By Alan, on April 20th, 2023%

First results of a clinical trial show a drug derived from plants to aid in smoking cessation helps cut the use of e-cigarettes among non-smokers of burning tobacco. . . . → Read More: Trial Shows Plant-Based Drug Helps Reduce Vaping

Trial to Test Low-Dose Psilocybin for Mental Distress

By Alan, on March 21st, 2023%

A developer of mental health therapies from psychedelic compounds says it received FDA clearance for a clinical trial testing low doses of psilocybin. . . . → Read More: Trial to Test Low-Dose Psilocybin for Mental Distress

Light-Activated Treatment Kills Covid-19 Nasal Viruses

By Alan, on January 31st, 2023%

Clinical trial findings show a light-activated disinfectant process kills SARS-CoV-2 viruses in the nose causing Covid-19 infections without harming nasal tissue. . . . → Read More: Light-Activated Treatment Kills Covid-19 Nasal Viruses

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise